Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • SGL: Hidden part in Bacteriophages could be a Protein Antibiotic

Graphene Nano-particles: Interrupts anxiety-related behaviour

NABI Research Associate & JRF Jobs With Rs. 47,000 pm Salary

SGL: Hidden part in Bacteriophages could be a Protein Antibiotic
  • BiotechToday
  • World

SGL: Hidden part in Bacteriophages could be a Protein Antibiotic

bioxone March 18, 2021March 18, 2021

Ayooshi Mitra, Amity University, Kolkata

Antibiotic-resistant bacteria are becoming a greater threat to human health day by day, necessitating the development of new antibiotics. Bacteriophages and their potential as antibacterial agents to combat pathogenic bacteria have sparked renewed interest. This is largely due to the phage’s ability to cause a cellular breakdown in the bacterial host via its ‘lysis genes.’ Most phages can rupture their host cell, a process known as lysis, wherein they release new phage virions known as “progeny” that are genetically and structurally identical to the parent virus.

Small phages produce a single protein that causes host lysis. Essentially, the virus produces a protein antibiotic that causes lysis in the same way that antibiotics like penicillin do – by interfering with the multistage process of cell wall biosynthesis. When an infected cell attempts to divide, it explodes because it is unable to form a new cell wall between the daughter cells. In a recent study conducted by researchers of Texas A&M University, it is said that the researchers believe that these small lysis proteins could serve as a model for a whole new class of antibiotics. The research points to the lysis of leviviruses, which are bacteriophages with single-stranded RNA genomes having three to four genes. There have been tens of thousands of leviviruses discovered. Sgl, which stands for “single gene lysis,” is one of the known levivirus genes. Sgl is a gene that produces a protein that causes bacteria to break down their cells. Sgl genes are found in many leviviruses, but they have remained “hidden” from researchers because they are small, diverse, and can be embedded within other genes.

The researchers said in an interview, that they wanted to discover these “hidden” genes and understand their structure and evolution so they can understand how these will be able to benefit the development of novel antibiotics. the researchers could recognise 35 different Sgls that had lytic or negative effects on E. coli bacteria. The researchers also discovered that each of these Sgls could represent a different mechanism for the lysis of host cells. According to previous research, single-stranded RNA phages have high mutation rates. These phages can infect new bacteria species thanks to their high mutation rates. The phages must either change the existing Sgl gene or evolve a new Sgl to escape the new hosts. Even though genomic RNA has a very short total length, these phages can encode two or more Sgls or proto-Sgls for lytic activity against multiple bacterial hosts.

The discovery that a large proportion of the Sgls found in the study originated and evolved within the gene for the phage replication protein, or Rep, was another far-reaching aspect of the research. Finally, according to the findings, Sgls are extremely diverse and have yet to be fully exploited as a source of peptides that could be used in protein antibiotics to attack bacteria’s cellular function. The researchers hope that their findings will aid in the discovery of small genes and their biological functions in RNA viruses found in more complex organisms like plants and animals and provide a model for studying the evolution of new genes.

Also read:An E-textile that controls biological energy when worn

Reference:

  1. “Rapid de novo evolution of lysis genes in single-stranded RNA phages” by Karthik R. Chamakura, Jennifer S. Tran, Chandler O’Leary, Hannah G. Lisciandro, Sophia F. Antillon, Kameron D. Garza, Elizabeth Tran, Lorna Min and Ry Young, 26 November 2020, Nature Communications.DOI: 10.1038/s41467-020-19860-0
  2. https://scitechdaily.com/hidden-genes-in-bacteriophages-could-be-key-in-development-of-new-antibiotics/amp/
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged antibacterial agent antibiotic-resistant antibiotics bacteria bacteriophage biosynthesis cellular breakdown host cell levivirus lysis RNA RNA virus SGL virion

One thought on “SGL: Hidden part in Bacteriophages could be a Protein Antibiotic”

  1. Pingback: Phantom Limb Pain - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

NABI Research Associate & JRF Jobs With Rs. 47,000 pm Salary

bioxone March 18, 2021

-Shristi Sharma, Team bioXone NABI Vacancies – JRF & Research Associate Posts Available. National Agri-Food Biotechnology Institute (NABI) is hiring for research positions. NABI job opportunity details, project details, application procedure details given below: National Agri-Food Biotechnology Institute (NABI) (Dept. of Biotechnology, Govt. of India) Sector-81, Knowledge City, Mohali P.O, S.A.S. Nagar-140306, Punjab, India. Website: […]

Related Post

  • BiotechToday
  • World

High-Grade Serous Ovarian Carcinoma & its radical treatment

bioxone August 7, 2021August 6, 2021

Srabani Roy Chowdhury (MAKAUT, WB) HGSC or High-Grade Serous Ovarian Carcinoma is considered to be an aggressive type of ovarian cancer. Deleterious mutations present in the DNA repair gene RAD51C are drivers of defective homologous recombination in High-Grade Serous Ovarian Carcinoma (HGSC). These are emerging biomarkers of PARP inhibitor sensitivity. A PARP inhibitor is targeted […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

TET and TDG in DNA demethylation

bioxone June 25, 2021June 24, 2021

Husna, Amity University Kolkata What is DNA demethylation? DNA cytosine methylation is controlled by the functional interplay between two families of enzymes: DNA methyltransferases (DNMTs) and TET methylcytosine dioxygenases, which control DNA methylation and demethylation, respectively. DNA demethylation, as the name suggests, is a process which involves the removal of a methyl group from cytosines. The […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • India

DRDO’s “2-DG” Anti-Covid Drug has been finally launched

bioxone May 18, 2021May 18, 2021

Anuska Sen, Team BioXone Abbreviations used in the following article: 2-DG: 2-deoxy-D-glucose DRDO: Defence Research and Development Organization INMAS: Institute of Nuclear Medicine and Allied Sciences DCGI: Drugs Controller General of India The 2-DG anti-covid drug jointly developed by DRDO’s INMAS laboratory and Dr. Reddy’s Laboratories has finally been launched yesterday (Monday, 17th May, 2021). […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy